Generally, most breast cancer cells present differential amounts of three significant biomarkers, i.e., the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [2]. This evidence concerns the gene ESR1 and breast carcinoma.